Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
Wensi Zhao, Shaobo Ke, Xiaojun Cai, Zhigang Zuo, Wei Shi, Hu Qiu and 5 more
- Rank
- 25 of 776
- Percentile
- top 3.3%
- Where
- Radiotherapy and Oncology, 2023
- Citations
- 45
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.